Global Statins Market size reached US$ 15 Bn in 2021 and is expected to touch US$ 22 Bn by 2032, advancing at 3.5% CAGR from 2022 to 2032 (forecast period)

The statins market is a sector of the pharmaceutical industry that deals with the production and distribution of statin drugs. Statins are medications that are used to lower cholesterol levels in the blood and reduce the risk of heart disease and stroke. They work by inhibiting the enzyme HMG-CoA reductase, which plays a key role in the production of cholesterol in the liver.

Request For Free Sample Report of “Statins Market”@ https://www.persistencemarketresearch.com/samples/3038

In 2022, the global statins market is expected to be worth billions of dollars, with a significant portion of the demand coming from developed countries such as the United States, Europe, and Japan. The market is highly competitive, with a number of large pharmaceutical companies producing and selling statins.

There are several factors that are expected to drive the growth of the statins market in 2022. One of the main drivers is the increasing prevalence of cardiovascular diseases, which are a major cause of mortality and morbidity worldwide. The aging population, rising levels of obesity, and increasing prevalence of diabetes are also contributing to the demand for statins. In addition, the increasing awareness of the importance of cholesterol management and the availability of a wide range of statins at different price points are expected to boost the market.

 Companies

  • Pfizer Inc.
  • AstraZeneca plc
  • Novartis International AG
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Biocon
  • Aurobindo Pharma Ltd
  • Concord Biotech

 Buy Full Report Now and Get Up to 20% Discount @ https://www.persistencemarketresearch.com/checkout/3038

However, the statins market is also facing some challenges. One of the main challenges is the increasing prevalence of generic statins, which are cheaper alternatives to brand-name statins. This trend is expected to put downward pressure on prices and reduce the profitability of the market. In addition, the potential side effects of statins, including muscle pain and weakness, are also a concern for some patients and may limit the demand for these drugs.

Overall, the statins market is expected to continue growing in 2022, driven by the increasing prevalence of cardiovascular diseases and the availability of a wide range of statins at different price points. However, the market is also facing some challenges, including the increasing prevalence of generic statins and concerns about the potential side effects of these drugs

Product Analysis

Statins are a special class of drugs that helps in lowering blood cholesterol level in the body. This is prescribed to lower the low density lipoprotein (LDL) cholesterol in the body and thus reduce mortality in high-risk patients. Demand for statins is long driven by increasing healthcare awareness among the common masses.

 

Though cholesterol level is easy to maintain provided one follows a healthy diet, sedentary lifestyle has been a major challenge over the past several years.

Over the past few years, the statins market has proved to be a lucrative and profitable market, especially for players that are focused on it. Consumption of statins is quite high among the geriatric population.

 Request Customization @ https://www.persistencemarketresearch.com/request-customization/3038

Statins Industry Research Segmentation

By Drug Class:

  • Astrovastatins
  • Fluvastatins
  • Lovastatins
  • Pravastatins
  • Simvastatins
  • Others

By Therapeutic Treatment:

  • Cardiovascular Disorders
  • Obesity
  • Inflammatory Disorders
  • Others

By End User:

  • Hospitals
  • Clinics

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

For More Premium Insights, Check out the Link:

Systemic Scleroderma Treatment Market

Primary Hepatocytes Market

Oncology Mice Models Market

About Us

Persistence Market Research’s Expertise in Life Sciences and Transformational Health

Our expert team of industry analysts comprising management graduates, medical professionals, engineers, and project managers provides insights on emerging therapy areas, diagnostic tools, medical devices and components, reimbursement and market access, biotechnology, and life science research products and services to equip decision-makers with sound inputs and strategic recommendations. Click here to learn more about how we zero in on the critical aspects of this industry.

Contact Us:

Persistence Market Research

Japan

Persistence Market Research

1-2-1 Kinshi Arca Central Building 14/F Tokyo, 130-0013 Japan

Call 0800-222-1088

United States

Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States

U.S. Ph. – +1-646-568-7751

USA-Canada Toll-free – +1 800-961-0353

Sales – [email protected]

Leave a Comment

%d bloggers like this: